It should also be noted that ICT seems to have the largest effects in subtypes which were suspected to suffer more from primary iron overload, MDS-RS and MDS-RA but not MDS-MLD, as marked by a reduced hepcidin/ferritin ratio described in section Elevated Iron Levels in MDS and AML Patients
We have seen that oral GLP-1 agonists alone are often insufficient to generate such significant results but using them as a tool to augment the results of the Allurion Program could be a promising treatment approach in the future. Allurion recently published findings indicating that providers are interested in combining the Allurion Program with anti-obesity medications and that the rise of GLP-1 agonists has increased patient inquiries and boosted awareness of weight loss treatments like the Allurion Program
Each subject may experience varying results depending on their age, diet, level of exercise, genetics, and other lifestyle factors
Sci Rep 10:21701
We registered this study prospectively in Open Science Framework, Search strategy and study eligibility We searched in four databases (PubMed, Embase, Cochrane Library, and Web of Science) from inception to 1 November 2022 for potentially relevant records without language restrictions (for search terms used, see the Appendix: Text S1)
Are injection site reactions a sign of Mounjaro allergy